Granules Quarterly Results for Trading Insights

GRANULES • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹131 Cr
QSept 2025
Quarterly Results

Granules Quarterly Results Key Highlights

  • Revenue of ₹1,294 Cr in Sept 2025 (+5.2% vs Mar 2025, +34.8% vs Sept 2024)
  • Net Profit of ₹131 Cr in Sept 2025 (-13.8% vs Mar 2025, +35.1% vs Sept 2024)
  • EBITDA of ₹275 Cr in Sept 2025 (-3.2% vs Mar 2025)
  • Operating Margin of 21.0% in Sept 2025 (+0.0pp vs Mar 2025)
  • Earnings Per Share of ₹5.38 in Sept 2025 (-14.2% vs Mar 2025)

Granules Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 1,294 1,230 1,225 960 1,171 5.2% 34.8%
Net Profit (₹ Cr) 131 152 113 97 130 - -
EBITDA (₹ Cr) 275 284 236 197 251 - -
EPS (₹) 5.38 6.27 4.64 4.01 5.35 - -
Operating Margin (%) 21.0% 21.0% 18.0% 20.0% 21.0% - -

Granules Share Price Trend Around Quarterly Results

Visualize Granules's 1-year price movement across quarterly results — ideal for logging trades in Granules share price chart using Tickjournal. All values in ₹.

Related Pages for Granules

Additional stock information and data for GRANULES

GRANULES market value
Granules annual reports
GRANULES 52-week chart
Granules dividend policy
GRANULES P/B ratio
GRANULES PE ratio trends
GRANULES fundamental worth

Profitability Ratios

Profit Margin 10.1%
EBITDA Margin 21.3%
Operating Margin 21.0%
ROE (Annual) 14.1%

Balance Sheet Highlights

Total Assets ₹6,253 Cr
Total Equity ₹3,716 Cr
Current Assets ₹3,116 Cr
Current Liabilities ₹534 Cr

Cash Flow Analysis

Operating Cash Flow ₹867 Cr
Investing Cash Flow ₹-689 Cr
Financing Cash Flow ₹-93 Cr
Net Cash Flow ₹85 Cr

Current Market Data

Current Price ₹601.95
Exchange NSE
Last Updated Jan 09, 2026

Revenue Trend (₹ Cr)

Sept 2024 960
Jun 2025 1,225
Mar 2025 1,230
Sept 2025 1,294

Net Profit Trend (₹ Cr)

Sept 2024 97
Jun 2025 113
Mar 2025 152
Sept 2025 131

Operating Margin Trend (%)

Sept 2024 20.0%
Jun 2025 18.0%
Mar 2025 21.0%
Sept 2025 21.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Granules quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹417,052.40 Cr 1729.9 14,875 3,125 +10.8% - 21.0% 133.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6616.5 2,860 689 +7.1% - 24.1% 254.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 3963.4 3,219 591 +11.3% - 18.4% 226.0
Cipla
Sept 2025 		₹118,572.82 Cr 1465.7 7,716 1,353 +12.0% - 17.5% 87.6
Dr Reddys Laborator…
Sept 2025 		₹100,998.62 Cr 1210.1 9,135 1,337 +1.1% - 14.6% 74.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores